home / stock / celu / celu news

CELU News and Press, Celularity Inc.

Stock Information
Company Name: Celularity Inc.
Stock Symbol: CELU
Market: NASDAQ
Website: celularity.com
Menu
CELU CELU Quote CELU Short CELU News CELU Articles CELU Message Board
Get CELU Alerts

News, Short Squeeze, Breakout and More Instantly...
CELU - Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 Million in net cash proceeds from the sale of approximately $126.3 Million of its unu...
CELU - Organogenesis, MiMedx among decliners as Medicare to pull skin substitute LCDs

2025-12-26 10:41:52 ET More on Organogenesis Holdings, MiMedx Group Organogenesis: High-Tech Skin Substitute Company On Sale Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript MiMedx: Breakout Setup Into A Policy Overhaul Organogenesis starts...

CELU - Organogenesis drops as Medicare to pull skin substitute LCDs (update)

2025-12-26 11:09:21 ET More on Organogenesis Holdings, MiMedx Group Organogenesis: High-Tech Skin Substitute Company On Sale Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript MiMedx: Breakout Setup Into A Policy Overhaul Organogenesis starts...

CELU - Celularity CEO Comments on Centers for Medicare & Medicaid Services' Withdrawal of Skin Substitute Local Coverage Determinations

FLORHAM PARK, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today released comments by Robert J. Hariri, M.D., Ph.D., CEO and Chairman, on the Cent...
CELU - Celularity Announces Closing of Financing Transactions

FLORHAM PARK, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today announced the closing of its previously disclosed financing transactions with Phi...

CELU - Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision

The contemplated financing transactions would provide up to $12 Million in capital to support Celularity’s strategic priorities around longevity and preservation of human performance. FLORHAM PARK, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celular...

CELU - Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, announced today a strategic partnership with DefEYE, Inc. (“DefEYE”), a n...
CELU - Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy under Florida statute (§ 458.3245), effective J...

CELU - Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance

Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively, in accord with its August 11, 2025 updated Nasdaq compliance plan. Company also announces notification by Nasdaq dated September 2, 2025, that it now...

CELU - US Companies Moving the Markets, Evening edition
Tue, Sep 02, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 14.4% to $5.09 on volume of 404,498,958 shares Carisma Therapeutics Inc. (CARM) rose 104.7% to $0.44 on volume of 369,969,532 shares HWH International Inc. (HWH) rose 227.8% to $4.72 on volume of 31...
Next 10